Press release Ecully, 1 JUNe 2021 – 5:45 p.m.
Signature a memorandum of understanding
for the acquisition of Distimp start–up
Spineway, specialized in innovatedtif implants for the treatment of severe spinal disorders (spine), signed a memorandum of understanding for the acquisition of 100% of Capital city – subject to compliance with the conditions precedent – by Distimp, a European departure–with which the Group entered into exclusive negotiations last March.1
Distimp, based in Nîmes, specializes in the design, manufacture and sale of implants and instruments for spine surgery. Its founder, Fabrice Paccagnella, brings to the company his solid experience acquired by working in the spine field in the design and development of implants and instruments for more than 25 years, giving him access to a large network of surgeons. of the spine, especially in France and Europe. The company has several lines of innovative products for spine surgery that it markets directly in France and through international distributors.
In line with the Group’s growth strategy, this acquisition will allow Spineway to consolidate its product range and strengthen its positions in Europe, particularly in France, by providing a wider variety of high added value surgical techniques intended for to spine surgeons.
This acquisition will be entirely financed in cash2 and Mr. Fabrice Paccagnella will be integrated into the Group upon the final signing of the agreement, which should take place at the end of June.
To come up: Half-year sales 2021 – July 13, 2021
SPINEWAY IS ELIGIBLE FOR PEA-PME (ACTION SAVINGS PLANS FOR SMES)
Find out all about Spineway at www.spineway.com
This press release has been drafted in English and French. In case of discrepancy, the French version will prevail.
Spineway designs, manufactures and markets innovative implants and surgical instruments for the treatment of severe spinal disorders.
Spineway has an international network of more than 50 independent distributors and 90% of its revenues come from exports.
Spineway, eligible for investment through FCPIs (French Unit Trusts specialized in innovation), has received the OSEO Excellence award since 2011 and won the Deloitte Fast 50 award (2011). Rhône Alpes INPI Brevet Innovation Award (2013) – INPI Talent Award (2015).
ISIN: FR0011398874 – ALSPW
Shareholder service line
Available from Tuesday to Thursday
(10h00 – 12h00)
+33 (0) 811 045 555
PEA / PME
|AELIUM Finance & Communication
1 See press release of March 18, 2021
2 A selling price paid in cash, and possibly additional payments due in 2022, 2023 and 2024 primarily based on average sales performance, gross margin and working capital.
SPW_CP ACCORD DISTIMP VDEF_GB